Related Experiment Video
Updated: Jan 10, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Deprioritized and disrupted: tuberculosis care in the shadow of COVID-19
1School of Public Health Sciences, Faculty of Health, University of Waterloo, Waterloo, ON, Canada.
Abstract:
The COVID-19 pandemic significantly disrupted tuberculosis (TB) care worldwide, undermining years of progress in TB prevention and control. This Perspective offers a comparative analysis of how TB services were affected in a high-income, low-burden country (Canada) versus two low- and middle-income, high-burden countries (India and Nigeria). Drawing on secondary data and global surveillance reports, the article highlights key disruptions across the TB care cascade, including delays in diagnosis, reduced case detection, and the collapse of community-based treatment models like DOTS. In Canada, digital transitions partially mitigated the impact, though access was unequal. In contrast, India and Nigeria faced widespread diagnostic interruptions, compounded by preexisting infrastructure gaps and limited digital access. The comparison reveals how underlying health system strength and digital readiness shaped national responses and recovery trajectories. Crucially, the pandemic exposed policy inertia and the deprioritization of routine infectious disease care in crisis contexts. This article calls for a global rethink of public health preparedness that centers on equity, continuity of essential services, and support for high burden settings. By analyzing divergent country experiences, this Perspective contributes actionable insights for strengthening TB programs and public health systems during future pandemics.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...

